Last updated on June 2018

Safety and Efficacy of VAY736 in Patients With Primary Sjogren's Syndrome (pSS)


Brief description of study

This study will determine the dose-response relationship of VAY736 for key efficacy and safety parameters

Clinical Study Identifier: NCT02962895

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Boca Raton, FL United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Jacksonville, FL United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Indianapolis, IN United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Rochester, NY United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
San Antonio, TX United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Buenos Aires, Argentina
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Caba, Argentina
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Tucuman, Argentina
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Graz, Austria
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Leuven, Belgium
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Brest, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Lille, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Berlin, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Freiburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Wurzburg, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Budapest, Hungary
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nagoya, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Nagasaki-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Sasebo-city, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Shinjuku-ku, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Rotterdam, Netherlands
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Lublin, Poland
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Lisboa, Portugal
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Ekaterinburg, Russian Federation
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Vigo, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Barcelona, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Kaohsiung, Taiwan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Taichung, Taiwan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Taipei, Taiwan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Liverpool, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Boston, MA United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
New York, NY United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Wexford, PA United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
North Charleston, SC United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Houston, TX United States
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Bruxelles, Belgium
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Santiago, Chile
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Le Kremlin Bicetre, France
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Muenchen, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
München, Germany
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Szeged, Hungary
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Jerusalem, Israel
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Ramat Gan, Israel
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Rozzano, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Roma, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Udine, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Coppito L Aquila, Italy
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Itabashi-ku, Japan
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Almada, Portugal
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Orenburg, Russian Federation
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
St Petersburg, Russian Federation
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
La Laguna, Spain
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Basildon, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Westcliff-on-Sea, United Kingdom
  Connect »

Novartis Pharmaceuticals

Novartis Investigative Site
Birmingham, United Kingdom
  Connect »